Besides common risk factors, such as arterial hypertension, valvular heart disease, and myocardial infarction, both diseases often share similar approaches to drug therapy such as beta-blockers, digoxin, and angiotensin-converting enzyme inhibitors. The gene discussed is ACE; the disease is myocardial infarction.